{"symbol": "MDGL", "companyName": "Madrigal Pharmaceuticals Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.madrigalpharma.com", "description": "Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).", "CEO": "Paul A. Friedman", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}